301333 诺思格
已收盘 02-06 15:00:00
资讯
新帖
简况
2月3日诺思格涨8.76%，信澳优享生活混合A基金重仓该股
证券之星 · 02-03
2月3日诺思格涨8.76%，信澳优享生活混合A基金重仓该股
诺思格（301333）3926.88万股限售股将于2月2日解禁，占总股本40.66%
证券之星 · 02-02
诺思格（301333）3926.88万股限售股将于2月2日解禁，占总股本40.66%
诺思格（301333）披露首次公开发行前已发行股份解除限售并上市流通提示性公告，1月27日股价下跌0.87%
证券之星 · 01-27
诺思格（301333）披露首次公开发行前已发行股份解除限售并上市流通提示性公告，1月27日股价下跌0.87%
1月23日诺思格涨5.13%，信澳优享生活混合A基金重仓该股
证券之星 · 01-23
1月23日诺思格涨5.13%，信澳优享生活混合A基金重仓该股
诺思格涨5.13%，太平洋二个月前给出“买入”评级
证券之星 · 01-23
诺思格涨5.13%，太平洋二个月前给出“买入”评级
1月16日诺思格跌5.15%，信澳优享生活混合A基金重仓该股
证券之星 · 01-16
1月16日诺思格跌5.15%，信澳优享生活混合A基金重仓该股
1月15日诺思格跌16.68%，信澳优享生活混合A基金重仓该股
证券之星 · 01-15
1月15日诺思格跌16.68%，信澳优享生活混合A基金重仓该股
诺思格：鉴于公司与客户普遍签署保密协议，不便披露具体信息
证券之星 · 01-15
诺思格：鉴于公司与客户普遍签署保密协议，不便披露具体信息
1月14日诺思格（301333）龙虎榜数据：游资瑞鹤仙上榜
证券之星 · 01-14
1月14日诺思格（301333）龙虎榜数据：游资瑞鹤仙上榜
诺思格涨8.13%，股价创历史新高
证券之星 · 01-14
诺思格涨8.13%，股价创历史新高
千亿出海+天价猴！CRO板块扎堆涨停，这波红利能吃到2026？
中金财经 · 01-13
千亿出海+天价猴！CRO板块扎堆涨停，这波红利能吃到2026？
异动快报：诺思格（301333）1月13日10点7分触及涨停板
证券之星 · 01-13
异动快报：诺思格（301333）1月13日10点7分触及涨停板
股市必读：诺思格（301333）1月7日董秘有最新回复
中金财经 · 01-08
股市必读：诺思格（301333）1月7日董秘有最新回复
股市必读：诺思格（301333）1月6日董秘有最新回复
证券之星 · 01-07
股市必读：诺思格（301333）1月6日董秘有最新回复
诺思格：合作涉及美国、欧洲、日本、韩国
证券之星 · 01-06
诺思格：合作涉及美国、欧洲、日本、韩国
每周股票复盘：诺思格（301333）董事减持3100股并选举为职工代表董事
证券之星 · 01-03
每周股票复盘：诺思格（301333）董事减持3100股并选举为职工代表董事
诺思格：12月29日高管乔宇航减持股份合计3100股
证券之星 · 2025-12-30
诺思格：12月29日高管乔宇航减持股份合计3100股
诺思格（301333）披露选举第五届董事会职工代表董事，12月29日股价上涨5.21%
证券之星 · 2025-12-29
诺思格（301333）披露选举第五届董事会职工代表董事，12月29日股价上涨5.21%
12月29日诺思格涨5.21%，信澳优享生活混合A基金重仓该股
证券之星 · 2025-12-29
12月29日诺思格涨5.21%，信澳优享生活混合A基金重仓该股
诺思格涨5.21%，太平洋一个月前给出“买入”评级
证券之星 · 2025-12-29
诺思格涨5.21%，太平洋一个月前给出“买入”评级
加载更多
公司概况
公司名称：
诺思格(北京)医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2022-08-02
主营业务：
诺思格(北京)医药科技股份有限公司的主营业务是为全球的医药企业和科研机构提供综合的药物临床研发全流程一体化服务。公司的主要产品是药物临床。
发行价格：
78.88
{"stockData":{"symbol":"301333","market":"SZ","secType":"STK","nameCN":"诺思格","latestPrice":79.04,"timestamp":1770361392000,"preClose":76.8,"halted":0,"volume":3050365,"delay":0,"changeRate":0.0292,"floatShares":96443700,"shares":96581299,"eps":1.5673,"marketStatus":"已收盘","change":2.24,"latestTime":"02-06 15:00:00","open":76.8,"high":80.5,"low":75,"amount":239000000,"amplitude":0.0716,"askPrice":79.05,"askSize":11,"bidPrice":79.04,"bidSize":129,"shortable":0,"etf":0,"ttmEps":1.5673,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":5,"adr":0,"adjPreClose":76.8,"symbolType":"stock","openAndCloseTimeList":[[1770341400000,1770348600000],[1770354000000,1770361200000]],"highLimit":84.48,"lowLimit":69.12,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":96581256,"isCdr":false,"pbRate":3.86,"roa":"--","peRate":50.430677,"roe":"5.08%","epsLYR":1.47,"committee":0.321168,"marketValue":7634000000,"turnoverRate":0.0316,"status":0,"floatMarketCap":7623000000},"requestUrl":"/m/hq/s/301333","defaultTab":"news","newsList":[{"id":"2608182693","title":"2月3日诺思格涨8.76%，信澳优享生活混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608182693","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608182693?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:50","pubTimestamp":1770108659,"startTime":"0","endTime":"0","summary":"证券之星消息，2月3日诺思格涨8.76%，收盘报78.98元，换手率4.48%，成交量4.32万手，成交额3.32亿元。重仓诺思格的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为信达澳亚基金的信澳优享生活混合A。该公募基金现任基金经理为杨珂。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300028357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1597","BK1237","BK1500","BK1553","301333","BK0216","01717"],"gpt_icon":0},{"id":"2608871368","title":"诺思格（301333）3926.88万股限售股将于2月2日解禁，占总股本40.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608871368","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608871368?lang=zh_cn&edition=full","pubTime":"2026-02-02 08:02","pubTimestamp":1769990534,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，诺思格于2月2日将有3926.88万股限售股份解禁，为公司追加承诺限售股份上市流通，占公司总股本40.66%。本次解禁后，公司还有13.75万股限售股份，占总股本0.14%。诺思格主营业务：临床试验运营服务、临床试验现场管理服务、生物样本检测服务、数据管理与统计分析服务、临床试验咨询服务、临床药理学服务等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200002728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2606780765","title":"诺思格（301333）披露首次公开发行前已发行股份解除限售并上市流通提示性公告，1月27日股价下跌0.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606780765","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606780765?lang=zh_cn&edition=full","pubTime":"2026-01-27 22:24","pubTimestamp":1769523863,"startTime":"0","endTime":"0","summary":"截至2026年1月27日收盘，诺思格报收于70.25元，较前一交易日下跌0.87%，最新总市值为67.85亿元。诺思格（北京）医药科技股份有限公司于2026年1月27日发布《关于首次公开发行前已发行股份解除限售并上市流通的提示性公告》。本次解除限售的股份上市流通日期为2026年2月2日。上述股东均已履行相关股份锁定承诺，本次解除限售股份不存在质押或冻结情形。本次解除限售后，公司有限售条件股份减少至137,520股，无限售条件股份相应增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700041915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2605160422","title":"1月23日诺思格涨5.13%，信澳优享生活混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2605160422","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605160422?lang=zh_cn&edition=full","pubTime":"2026-01-23 15:47","pubTimestamp":1769154420,"startTime":"0","endTime":"0","summary":"证券之星消息，1月23日诺思格涨5.13%，收盘报73.6元，换手率7.51%，成交量4.29万手，成交额3.11亿元。重仓诺思格的公募基金请见下表：该股最近90天内共有5家机构给出评级，买入评级3家，增持评级2家；过去90天内机构目标均价为88.4。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为信达澳亚基金的信澳优享生活混合A。该公募基金现任基金经理为杨珂。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300020073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1597","BK1237","BK1500","BK1553","301333","BK0216","01717"],"gpt_icon":0},{"id":"2605121422","title":"诺思格涨5.13%，太平洋二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2605121422","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605121422?lang=zh_cn&edition=full","pubTime":"2026-01-23 15:46","pubTimestamp":1769154413,"startTime":"0","endTime":"0","summary":"今日诺思格涨5.13%，收盘报73.6元。2025年10月31日，太平洋研究员周豫,张崴发布了对诺思格的研报《Q3收入稳健增长，利润增速超预期》，该研报对诺思格给出“买入”评级。研报中预计2025年-2027年公司营收为7.76/8.52/9.69亿元，同比增长4.33%/9.75%/13.79%；归母净利为1.50/1.63/1.81亿元，同比增长6.85%/8.83%/11.26%，对应PE为33/31/28倍，持续给予“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为太平洋的周豫、张崴。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300020069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","301333"],"gpt_icon":0},{"id":"2603968222","title":"1月16日诺思格跌5.15%，信澳优享生活混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603968222","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603968222?lang=zh_cn&edition=full","pubTime":"2026-01-16 15:43","pubTimestamp":1768549387,"startTime":"0","endTime":"0","summary":"证券之星消息，1月16日诺思格跌5.15%，收盘报72.08元，换手率8.56%，成交量4.9万手，成交额3.58亿元。重仓诺思格的公募基金请见下表：该股最近90天内共有5家机构给出评级，买入评级3家，增持评级2家；过去90天内机构目标均价为88.4。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为信达澳亚基金的信澳优享生活混合A。该公募基金现任基金经理为杨珂。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600019566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1553","BK1597","BK1237","01717","BK1500","BK0216","301333"],"gpt_icon":0},{"id":"2603674300","title":"1月15日诺思格跌16.68%，信澳优享生活混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603674300","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603674300?lang=zh_cn&edition=full","pubTime":"2026-01-15 15:42","pubTimestamp":1768462972,"startTime":"0","endTime":"0","summary":"证券之星消息，1月15日诺思格跌16.68%，收盘报75.99元，换手率12.89%，成交量7.37万手，成交额5.66亿元。重仓诺思格的公募基金请见下表：该股最近90天内共有5家机构给出评级，买入评级3家，增持评级2家；过去90天内机构目标均价为88.4。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为信达澳亚基金的信澳优享生活混合A。该公募基金现任基金经理为杨珂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500020091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333","BK1500","01717","BK1597","BK1237","BK1553"],"gpt_icon":0},{"id":"2603199627","title":"诺思格：鉴于公司与客户普遍签署保密协议，不便披露具体信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2603199627","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603199627?lang=zh_cn&edition=full","pubTime":"2026-01-15 11:36","pubTimestamp":1768448172,"startTime":"0","endTime":"0","summary":"证券之星消息，诺思格(301333)01月14日在投资者关系平台上答复投资者关心的问题。投资者提问：公司在国内外市场建立了良好口碑，众多优质的医药企业客户与公司保持长期稳固的合作关系。请问主要是哪些优质的医药企业客户呢？诺思格回复：尊敬的投资者您好！鉴于公司与客户普遍签署保密协议，不便披露具体信息。谢谢您的理解。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500015664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2603691337","title":"1月14日诺思格（301333）龙虎榜数据：游资瑞鹤仙上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2603691337","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603691337?lang=zh_cn&edition=full","pubTime":"2026-01-14 17:31","pubTimestamp":1768383096,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年1月14日公布的交易公开信息显示，诺思格因连续三个交易日内，涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年1月14日收盘，诺思格报收于91.2元，上涨19.25%，换手率22.62%，成交量12.93万手，成交额11.01亿元。瑞鹤仙等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400029668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2603665936","title":"诺思格涨8.13%，股价创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2603665936","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603665936?lang=zh_cn&edition=full","pubTime":"2026-01-14 10:59","pubTimestamp":1768359540,"startTime":"0","endTime":"0","summary":"诺思格股价创出历史新高，截至9:40，该股上涨8.13%，股价报82.70元，成交量321.86万股，成交金额2.53亿元，换手率5.63%，该股最新A股总市值达79.87亿元，该股A股流通市值47.28亿元。证券时报数据宝统计显示，诺思格所属的医药生物行业，目前整体涨幅为1.24%，行业内，目前股价上涨的有380只，涨停的有新里程、美年健康等3只。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-14/doc-inhhfvyv8460897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2603750260","title":"千亿出海+天价猴！CRO板块扎堆涨停，这波红利能吃到2026？","url":"https://stock-news.laohu8.com/highlight/detail?id=2603750260","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603750260?lang=zh_cn&edition=full","pubTime":"2026-01-13 17:30","pubTimestamp":1768296601,"startTime":"0","endTime":"0","summary":"据悉，2025年国内创新药BD出海金额突破1000亿美元，2026年预期加速，CRO企业作为研发外包核心服务商直接受益于订单放量。另外，2025年12月，广东、广西等地猴场实验猴已订至2026年上半年，供不应求局面持续，推动CRO企业战略资源溢价。一猴难求除了创新药出海带来的订单红利，实验猴资源的稀缺性进一步推升了CRO企业的战略价值。机构看好企业发展前景机构普遍看好CRO板块2026年的发展前景。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/13/20260113553813.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/13/20260113553813.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260113/31938136.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301230","BK0197","BK0028","BK0070","301060","BK0216","301333","06978","688137","BK0186","301257","BK1574","300244","BK1161","BK0236","BK0114","BK0146","BK0042","300404"],"gpt_icon":0},{"id":"2603575931","title":"异动快报：诺思格（301333）1月13日10点7分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2603575931","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603575931?lang=zh_cn&edition=full","pubTime":"2026-01-13 10:10","pubTimestamp":1768270238,"startTime":"0","endTime":"0","summary":"证券之星1月13日盘中消息，10点7分诺思格（301333）触及涨停板。其所属行业医疗服务目前上涨。领涨股为泓博医药。该股为创新药，医药概念热股，当日创新药概念上涨2.78%，医药概念上涨2.09%。1月12日的资金流向数据方面，主力资金净流出2188.89万元，占总成交额15.54%，游资资金净流入1563.12万元，占总成交额11.1%，散户资金净流入625.77万元，占总成交额4.44%。近5日资金流向一览见下表：诺思格主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300010719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2601877003","title":"股市必读：诺思格（301333）1月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601877003","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601877003?lang=zh_cn&edition=full","pubTime":"2026-01-08 08:06","pubTimestamp":1767830766,"startTime":"0","endTime":"0","summary":"h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2026年1月7日收盘，诺思格报收于61.68元，上涨0.19%，换手率4.19%，成交量2.4万手，成交额1.5亿元。其中欧洲市场主要和哪些国家合作呢？鉴于公司与客户普遍签署保密协议，不便披露具体信息。 来自交易信息汇总：1月7日主力资金净流入194.46万元，显示主力对个股短期态度偏积极。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260108/31924265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2601817031","title":"股市必读：诺思格（301333）1月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601817031","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601817031?lang=zh_cn&edition=full","pubTime":"2026-01-07 03:21","pubTimestamp":1767727270,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘，诺思格报收于61.56元，下跌0.36%，换手率3.51%，成交量2.0万手，成交额1.23亿元。董秘最新回复投资者： 公司已为国内外众多优质客户的多项临床试验项目提供符合国内外标准的临床试验外包服务，请问公司具体合作的海外国家有哪些？公司与海外多个药企有合作，主要涉及美国、欧洲、日本、韩国等。交易信息汇总资金流向1月6日主力资金净流出424.23万元；游资资金净流入648.3万元；散户资金净流出224.07万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700001481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2601861838","title":"诺思格：合作涉及美国、欧洲、日本、韩国","url":"https://stock-news.laohu8.com/highlight/detail?id=2601861838","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601861838?lang=zh_cn&edition=full","pubTime":"2026-01-06 15:03","pubTimestamp":1767682993,"startTime":"0","endTime":"0","summary":"证券之星消息，诺思格(301333)01月06日在投资者关系平台上答复投资者关心的问题。投资者提问：公司已为国内外众多优质客户的多项临床试验项目提供符合国内外标准的临床试验外包服务，请问公司具体合作的海外国家有哪些？诺思格回复：尊敬的投资者您好！公司与海外多个药企有合作，主要涉及美国、欧洲、日本、韩国等。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600019749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2600060360","title":"每周股票复盘：诺思格（301333）董事减持3100股并选举为职工代表董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2600060360","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600060360?lang=zh_cn&edition=full","pubTime":"2026-01-03 03:33","pubTimestamp":1767382390,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，诺思格报收于59.55元，较上周的58.37元上涨2.02%。股本股东变化高管增减持2025年12月29日，诺思格董事乔宇航减持公司股份3100.0股，占公司总股本的0.0032%。公司公告汇总关于选举第五届董事会职工代表董事的公告2025年12月29日，诺思格召开职工代表大会，选举乔宇航为第五届董事会职工代表董事，任期至本届董事会届满。董事会中兼任高管及职工代表董事人数未超过董事总数的二分之一，符合相关规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2595797371","title":"诺思格：12月29日高管乔宇航减持股份合计3100股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595797371","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595797371?lang=zh_cn&edition=full","pubTime":"2025-12-30 21:03","pubTimestamp":1767099817,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月30日市场公开信息、上市公司公告及交易所披露数据整理，诺思格最新董监高及相关人员股份变动情况：2025年12月29日公司董事乔宇航共减持公司股份3100.0股，占公司总股本为0.0032%。变动期间公司股价上涨5.21%，12月29日当日收盘报61.41元。诺思格近半年内的董监高及核心技术人员增减持详情如下：诺思格的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出266.68万，融资余额减少；融券净流出100.0，融券余额减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000041313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2595773524","title":"诺思格（301333）披露选举第五届董事会职工代表董事，12月29日股价上涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595773524","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595773524?lang=zh_cn&edition=full","pubTime":"2025-12-29 22:24","pubTimestamp":1767018261,"startTime":"0","endTime":"0","summary":"截至2025年12月29日收盘，诺思格报收于61.41元，较前一交易日上涨5.21%，最新总市值为59.31亿元。公司近日发布公告称，诺思格（北京）医药科技股份有限公司于2025年12月29日召开职工代表大会，选举乔宇航先生为公司第五届董事会职工代表董事，任期自审议通过之日起至第五届董事会任期届满。本次选举后，公司董事会中兼任高管及职工代表董事人数未超过董事总数的二分之一，符合相关规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900037917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2595120708","title":"12月29日诺思格涨5.21%，信澳优享生活混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595120708","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595120708?lang=zh_cn&edition=full","pubTime":"2025-12-29 15:39","pubTimestamp":1766993943,"startTime":"0","endTime":"0","summary":"证券之星消息，12月29日诺思格涨5.21%，收盘报61.41元，换手率7.49%，成交量4.28万手，成交额2.6亿元。重仓诺思格的公募基金请见下表：该股最近90天内共有5家机构给出评级，买入评级3家，增持评级2家；过去90天内机构目标均价为88.4。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为信达澳亚基金的信澳优享生活混合A。该公募基金现任基金经理为杨珂。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900014582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1597","BK0216","BK1553","BK1237","301333","BK1500","01717"],"gpt_icon":0},{"id":"2595055207","title":"诺思格涨5.21%，太平洋一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2595055207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595055207?lang=zh_cn&edition=full","pubTime":"2025-12-29 15:38","pubTimestamp":1766993935,"startTime":"0","endTime":"0","summary":"今日诺思格涨5.21%，收盘报61.41元。2025年10月31日，太平洋研究员周豫,张崴发布了对诺思格的研报《Q3收入稳健增长，利润增速超预期》，该研报对诺思格给出“买入”评级。研报中预计2025年-2027年公司营收为7.76/8.52/9.69亿元，同比增长4.33%/9.75%/13.79%；归母净利为1.50/1.63/1.81亿元，同比增长6.85%/8.83%/11.26%，对应PE为33/31/28倍，持续给予“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为太平洋的周豫、张崴。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900014577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","601099"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770382341907,"stockEarnings":[{"period":"1week","weight":0.0722},{"period":"1month","weight":0.2476},{"period":"3month","weight":0.211},{"period":"6month","weight":0.4251},{"period":"1year","weight":0.5937},{"period":"ytd","weight":0.2897}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":-0.0019},{"period":"3month","weight":0.0196},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.2621},{"period":"ytd","weight":0.027}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"诺思格(北京)医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"8734人(较上一季度减少16.18%)","perCapita":"11042股","listingDate":"2022-08-02","address":"北京市通州区经济开发区东区创益西路518号","registeredCapital":"9658万元","survey":" 诺思格(北京)医药科技股份有限公司的主营业务是为全球的医药企业和科研机构提供综合的药物临床研发全流程一体化服务。公司的主要产品是药物临床。","listedPrice":78.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺思格(301333)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺思格(301333)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺思格,301333,诺思格股票,诺思格股票老虎,诺思格股票老虎国际,诺思格行情,诺思格股票行情,诺思格股价,诺思格股市,诺思格股票价格,诺思格股票交易,诺思格股票购买,诺思格股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺思格(301333)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺思格(301333)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}